| ADAPTIVE BIOTECHNOLOGIES |
| USA |
| Gesundheit |
| US00650F1093 / A2PLR5 |
| 1HM (Frankfurt) / ADPT (NASDAQ) |
| FRA:1HM, ETR:1HM, 1HM:GR, NASDAQ:ADPT |
| - |
| https://www.adaptivebiote.. |
|
Adaptive Biotechnologies Corporation Common Stock represents the equity of Adaptive Biotechnologies Corporation, a commercial-stage biotechnology company focused on immune medicine. The company develops products and services that use immunosequencing..
>Volltext.. |
| 3740.14 Mio. EUR |
| 3804.83 Mio. EUR |
| 274.73 Mio. EUR |
| -18.07 Mio. EUR |
| -56.94 Mio. EUR |
| -0.36 EUR |
| 366.06 Mio. EUR |
| 151.48 Mio. EUR |
| -18.73 Mio. EUR |
| 3.92 |
| 54.85% |
| 45.67% |
| - |
| - |
| - |
| 3 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 5.508.790 Euro. |
| ADAPTIVE BIOTECHNOLOGIES, ADAPTIVE BIO, ADAPTIVE BIOTECH |
| 09.10.26 |